Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Dyspareunia × Breast × Clear all

Phase

Status

Completed 5 Unknown 3 Withdrawn 1 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Breast 1

Conditions

Breast Neoplasms 1630 Triple Negative Breast Neoplasms 266 Ovarian Neoplasms 123 Colorectal Neoplasms 112 Lung Neoplasms 102 Carcinoma, Non-Small-Cell Lung 96 Prostatic Neoplasms 94 Neoplasms 93 Neoplasm Metastasis 83 Stomach Neoplasms 78 Pancreatic Neoplasms 74 Melanoma 65 Endometrial Neoplasms 60 Uterine Cervical Neoplasms 56 Head and Neck Neoplasms 50 Squamous Cell Carcinoma of Head and Neck 48 Esophageal Neoplasms 42 Colonic Neoplasms 41 Urinary Bladder Neoplasms 39 Sarcoma 35 Motor Activity 35 Carcinoma, Intraductal, Noninfiltrating 34 Carcinoma, Renal Cell 30 Liver Neoplasms 29 HER2-positive Breast Cancer 29 Brain Neoplasms 28 Advanced Breast Cancer 23 Lymphedema 21 Breast Cancer Female 21 Carcinoma, Transitional Cell 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06347926 2025-11-18

EVABIOSEIN

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Recruiting

Breast Neoplasms, Dyspareunia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡